SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms-Reference-Cited by-同舟云学术

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms

Published:2021-05 Issue:10 Volume:184 Page:2605-2617.e18
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Clark Sarah A.,Clark Lars E.,Pan Junhua,Coscia Adrian,McKay Lindsay G.A.,Shankar Sundaresh,Johnson Rebecca I.,Brusic Vesna,Choudhary Manish C.,Regan James,Li Jonathan Z.,Griffiths Anthony,Abraham Jonathan

Funder

U.S. Department of Energy

Office of Research Infrastructure Programs, National Institutes of Health

National Institute of General Medical Sciences

Office of Science

Argonne National Laboratory

Harvard University

National Institutes of Health

Nancy Lurie Marks Family Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Passive antibody therapy in COVID-19;Abraham;Nat. Rev. Immunol.,2020

2. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

3. A time- and cost-efficient system for high-level protein production in mammalian cells;Aricescu;Acta Crystallogr. D Biol. Crystallogr.,2006

4. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer;Avanzato;Cell,2020

5. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies;Baum;Science,2020

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape;Viruses;2024-09-09

2. Structural review of SARS-CoV-2 antiviral targets;Structure;2024-09

3. Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants;Nature Communications;2024-08-31

4. Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection;Journal of Infection and Chemotherapy;2024-08

5. Shifts in receptors during submergence of an encephalitic arbovirus;Nature;2024-07-24